Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on equity (ROE) high or low?
The return on equity (ROE) of 73.08% is 207% above its 5-year average of -68.20%, near the high end of its 5-year range (-614.42%–79.21%).
As of the fiscal period ended Tuesday, June 30, 2026. 15.32% above its 12-month average of 63.37%.
Trailing-twelve-month return on equity at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): 73.08%.
RETURN ON EQUITY (ROE)
73.08%
RETURN ON EQUITY (ROE) AVG TTM
63.37%
RETURN ON EQUITY (ROE) AVG 3Y
34.02%
RETURN ON EQUITY (ROE) AVG 5Y
-68.20%
RETURN ON EQUITY (ROE) AVG 10Y
-104.40%
RETURN ON EQUITY (ROE) AVG 15Y
-76.98%
RETURN ON EQUITY (ROE) AVG 20Y
-87.81%
CURRENT VS TTM AVG
+15.32%
CURRENT VS 3Y AVG
+114.85%
CURRENT VS 5Y AVG
+207.15%
CURRENT VS 10Y AVG
+170.00%
CURRENT VS 15Y AVG
+194.94%
CURRENT VS 20Y AVG
+183.23%
SECTOR MEDIAN · HEALTHCARE
-42.01%
median of 754 covered companies
CURRENT VS SECTOR MEDIAN
+273.97%
vs the sector median at left
TG Therapeutics, Inc.
Market Cap
$7.99B
Return on Equity (ROE)
73.08%
TTM Avg
63.37%
3Y Avg
34.02%
5Y Avg
-68.20%
Market Cap
$7.77B
Return on Equity (ROE)
17.77%
TTM Avg
-40.95%
3Y Avg
-11.78%
5Y Avg
-8.64%
Market Cap
$7.66B
Return on Equity (ROE)
-25.29%
TTM Avg
-37.79%
3Y Avg
-133.44%
5Y Avg
-103.64%
Market Cap
$7.63B
Return on Equity (ROE)
11.88%
TTM Avg
7.39%
3Y Avg
4.04%
5Y Avg
2.40%
Market Cap
$7.58B
Return on Equity (ROE)
N/A
TTM Avg
277.25%
3Y Avg
262.80%
5Y Avg
141.77%
Market Cap
$8.40B
Return on Equity (ROE)
26.84%
TTM Avg
-21.41%
3Y Avg
-36.14%
5Y Avg
-25.75%
Market Cap
$7.59B
Return on Equity (ROE)
31.68%
TTM Avg
-71.21%
3Y Avg
-55.91%
5Y Avg
-55.91%
Market Cap
$8.65B
Return on Equity (ROE)
-19.85%
TTM Avg
-23.25%
3Y Avg
-28.82%
5Y Avg
-25.53%
Market Cap
$8.68B
Return on Equity (ROE)
-68.73%
TTM Avg
-161.81%
3Y Avg
-110.86%
5Y Avg
-82.70%
| NAME | MARKET CAP | RETURN ON EQUITY (ROE) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| TG Therapeutics, Inc. (TGTX) | $7.99B | 73.08% | 63.37% | 34.02% | -68.20% |
| Caris Life Sciences, Inc. (CAI)vs › | $7.77B | 17.77% | -40.95% | -11.78% | -8.64% |
| Praxis Precision Medicines, Inc. (PRAX)vs › | $7.66B | -25.29% | -37.79% | -133.44% | -103.64% |
| HealthEquity, Inc. (HQY)vs › | $7.63B | 11.88% | 7.39% | 4.04% | 2.40% |
| Cytokinetics, Incorporated (CYTK)vs › | $7.58B | N/A | 277.25% | 262.80% | 141.77% |
| Oscar Health, Inc. (OSCR)vs › | $8.40B | 26.84% | -21.41% | -36.14% | -25.75% |
| Hinge Health, Inc. (HNGE)vs › | $7.59B | 31.68% | -71.21% | -55.91% | -55.91% |
| Kymera Therapeutics, Inc. (KYMR)vs › | $8.65B | -19.85% | -23.25% | -28.82% | -25.53% |
| Arrowhead Pharmaceuticals, Inc. (ARWR)vs › | $8.68B | -68.73% | -161.81% | -110.86% | -82.70% |
| Ionis Pharmaceuticals, Inc. (IONS)vs › | $7.28B | -128.44% | -77.53% | -74.21% | -60.06% |
ROE
73.1%
ROA
26.9%
ROE = Net Income / Total Shareholders' Equity
Return on equity measures how efficiently a company generates profit from shareholders' equity. Higher ROE indicates better capital efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON EQUITY (ROE) |
|---|---|
| 2026-06-30 | 73.08% |
| 2026-03-31 | 79.21% |
| 2025-12-31 | 69.01% |
| 2025-09-30 | 73.69% |
| 2025-06-30 | 21.87% |
| 2025-03-31 | 16.50% |
| 2024-12-31 | 10.52% |
| 2024-09-30 | -7.48% |
| 2024-06-30 | 53.89% |
| 2024-03-31 | 25.73% |
| 2023-12-31 | 7.90% |
| 2023-09-30 | -15.72% |
| 2023-06-30 | -434.22% |
| 2023-03-31 | -614.42% |
| 2022-12-31 | -338.53% |
| 2022-09-30 | -237.54% |
| 2022-06-30 | -223.58% |
| 2022-03-31 | -191.61% |
| 2021-12-31 | -146.78% |
| 2021-09-30 | -110.10% |
| 2021-06-30 | -89.92% |
| 2021-03-31 | -71.62% |
| 2020-12-31 | -53.79% |
| 2020-09-30 | -135.20% |
| 2020-06-30 | -105.80% |
| 2019-12-31 | -447.68% |
| 2019-03-31 | -867.92% |
| 2018-12-31 | -721.76% |
| 2018-09-30 | -209.75% |
| 2018-06-30 | -146.06% |
| 2018-03-31 | -155.20% |
| 2017-12-31 | -176.85% |
| 2017-09-30 | -139.91% |
| 2017-06-30 | -134.13% |
| 2017-03-31 | -91.18% |
| 2016-12-31 | -218.17% |
| 2016-09-30 | -127.20% |
| 2016-06-30 | -77.53% |
| 2016-03-31 | -69.56% |
| 2015-12-31 | -61.97% |
| 2015-09-30 | -55.14% |
| 2015-06-30 | -60.14% |
| 2015-03-31 | -59.13% |
| 2014-12-31 | -69.64% |
| 2014-09-30 | -63.58% |
| 2014-06-30 | -57.11% |
| 2014-03-31 | -44.74% |
| 2013-12-31 | -51.13% |
| 2013-09-30 | -40.94% |
| 2013-06-30 | -157.47% |
| 2013-03-31 | -78.17% |
| 2012-12-31 | -116.22% |
| 2012-09-30 | -168.21% |
| 2012-06-30 | -125.76% |
| 2012-03-31 | -127.29% |
| 2011-12-31 | -8.86% |
| 2007-06-30 | -454.58% |
| 2007-03-31 | -138.04% |
| 2006-12-31 | -672.05% |
| 2006-09-30 | -244.10% |
| 2006-06-30 | -172.48% |
| 2006-03-31 | -292.11% |
| 2005-12-31 | -200.63% |
| 2005-09-30 | -162.85% |
| 2005-03-31 | -199.52% |
| 2004-12-31 | -132.38% |
| 2004-09-30 | -92.03% |
| 2004-06-30 | -80.73% |
| 2004-03-31 | -72.11% |
| 2003-12-31 | -87.24% |
| 2003-06-30 | -84.53% |
